Skip to main content
SpringerLink
Log in

Hepatobiliary disorders

  • Chapter
Book cover Inflammatory Bowel Disease: From Bench to Bedside

  • 1268 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas CH. Ulceration of the colon with a much enlarged fatty liver. Trans Pathol Soc Phil 1873; 4: 87–8.

    Google Scholar 

  2. Lister JD. A specimen of diffuse ulcerative colitis with secondary diffuse hepatitis. Trans Path Soc Lond 1988; 50: 130–5.

    Google Scholar 

  3. Perret AD, Higgins G, Johnston HH, Massarella G, Truelove SC, Wright R. The liver in ulcerative colitis. Q Med 1971; 40: 211–38.

    Google Scholar 

  4. Perret AD, Higgins G, Johnston HH, Massarella G, Truelove SC, Wright R. The liver in Crohn’s disease. Q Med 1971; 40: 187–209.

    Google Scholar 

  5. Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjome E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand Gastroenterol 1982; 17: 33–9.

    CAS  Google Scholar 

  6. Olsson R, Danielson A, Jarnerot G, Lindstrome, Loof L, Rolny P. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–23.

    PubMed  CAS  Google Scholar 

  7. Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum levels of alkaline phosphatase. Gastroenterology 1988; 95: 1395–8.

    PubMed  CAS  Google Scholar 

  8. Rasmussen HH, Fallingborg JF, Mortensen PB, Vyberg M, Tage-Jensen U, Rasmussen SN. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn’s disease. Scand J Gastroenterol 1997; 32: 604–10.

    PubMed  CAS  Google Scholar 

  9. Tobias R, Wright J, Kottler R. Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975–1981. S Afr Med J 1983; 63: 229–35.

    PubMed  CAS  Google Scholar 

  10. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroen-terology 1980; 79: 200–6.

    CAS  Google Scholar 

  11. Broome V, Glaumann H, Hultcrantz R. Liver histology and follow-up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990; 31: 468–72.

    PubMed  CAS  Google Scholar 

  12. Chapman RW, Arborgh BA, Rhodes JM et al. Primary sclerosing cholangitis — a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870–7.

    PubMed  CAS  Google Scholar 

  13. Escorsell A, Pares A, Rodes J, Soli-Herruzo J, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 1994; 21: 787–91.

    PubMed  CAS  Google Scholar 

  14. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996; 8: 685–91.

    PubMed  CAS  Google Scholar 

  15. Takikawa H. Recent status of primary sclerosing cholangitis in Japan. J Hepatol Bil Pane Surg 1999; 6: 352–5.

    CAS  Google Scholar 

  16. Lundgrist K, Broome U. Differences in colonic disease activity in patients with primary sclerosing cholangitis. Dis Colon Rectum 1997; 40: 1–6

    Google Scholar 

  17. Rabinovitz M, Gavalier JS, Schade RR, Dindzans VJ, Chien M-C, VanThiel DH. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease. Hepatology 1991; 11: 7–11.

    Google Scholar 

  18. Loftus Ev Jr, Sandborn WJ, Tremaine WJ et al. Primary sclerosing cholangitis is associated with non-smoking: a case-control study. Gastroenterology 1996; 110: 1496–502.

    PubMed  Google Scholar 

  19. Van Erpecium KJ, Smits SJ, Van-de-Meeberg PC et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behaviour. Gastroenterology 1996; 110: 1503–6.

    Google Scholar 

  20. Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002; 51: 1–6.

    Google Scholar 

  21. Nemeth A, Ejderhamn J, Glaumann H, Strandvik B. Liver damage in juvenile inflammatory bowel disease. Liver 1990; 10: 239–48.

    PubMed  CAS  Google Scholar 

  22. Wiesner RH, La Russo NF, Dozois RR, Beaver SJ. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 1986; 90: 316–22.

    PubMed  CAS  Google Scholar 

  23. Bargen JA. Chronic ulcerative colitis associated with malignant change. Arch Surg 1928; 17: 561–76

    Google Scholar 

  24. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404–8.

    PubMed  CAS  Google Scholar 

  25. Jayaram H, Satsangi J, Chapman RWG. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 2001; 48: 430–4.

    PubMed  CAS  Google Scholar 

  26. Marchesa P, Lashner BA, Lavery IC et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92: 1285–8.

    PubMed  CAS  Google Scholar 

  27. Shetty K, Rybicki L Bzezinski A, Carey WD, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999; 94: 1643–9.

    PubMed  CAS  Google Scholar 

  28. Lindberg B, Broome U, Persson B. Proximal colorectal dysplasia/cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum 2001; 44: 77–85.

    PubMed  CAS  Google Scholar 

  29. Broomé U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404–8.

    PubMed  Google Scholar 

  30. Miki C, Harrison JD, Gunson BK, Buckels JA, McMaster P, Mayer AD. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation. Br J Surg 1995; 82: 1114–17.

    PubMed  CAS  Google Scholar 

  31. Papatheodoridis GV, Hamilton M, Rolles K et al. Liver transplantation and inflammatory bowel disease. J Hepatol 1998; 28: 1070–6.

    PubMed  CAS  Google Scholar 

  32. Gavaler JS, Delemos B, Belle SH et al. Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci 1991; 36: 321–8.

    PubMed  CAS  Google Scholar 

  33. Shaked A, Colonna JO, Goldstein L et al. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992; 215: 598–603.

    PubMed  CAS  Google Scholar 

  34. Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver 2000; 20: 97–103.

    PubMed  CAS  Google Scholar 

  35. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451–7.

    Article  PubMed  CAS  Google Scholar 

  36. Penna C, Duzois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9.

    PubMed  CAS  Google Scholar 

  37. Pemberton JH. The role of proctocolectomy in patients with primary sclerosing cholangitis and inflammatory bowel disease. 2000 Clinical Research Single Topic Conference. Primary Sclerosing Cholangitis: Controversies and Consensus. AASLD.

    Google Scholar 

  38. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99–103.

    PubMed  CAS  Google Scholar 

  39. Quigley EMM, La Russo NF, Ludwig J, MacSween RNM, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterolgy 1983; 85: 1160–5.

    CAS  Google Scholar 

  40. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983; 24: 38–41.

    PubMed  CAS  Google Scholar 

  41. Schrumpf E, Fausa O, Forre O, Doblong JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982; 17: 187–91.

    PubMed  CAS  Google Scholar 

  42. Donaldson PT, Farrant JM, Wilkinson MK, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129–33.

    PubMed  CAS  Google Scholar 

  43. Olerup O, Olsson R, Hultcrantz R, Broomé U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870–8.

    PubMed  CAS  Google Scholar 

  44. Mitchell SA, Grove J, Spurkland A et al. Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001;49: 288–94.

    PubMed  CAS  Google Scholar 

  45. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999; 30: 237–41.

    PubMed  CAS  Google Scholar 

  46. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B80DR3 haplotype including particular MICA and MICB alleles. Hepatology 2001; 34: 625–30.

    PubMed  CAS  Google Scholar 

  47. Norris S, Kondeatis, Collins R et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 2001; 120: 1475–82.

    PubMed  CAS  Google Scholar 

  48. Satsangi J, Chapman RW, Haldar N et al. A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 2001; 121: 124–30.

    PubMed  CAS  Google Scholar 

  49. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsey KL, Wiesner RH. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1381–5.

    Google Scholar 

  50. Lo SK, Fleming KA, Chapman RW. Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992; 33: 1370–5.

    PubMed  CAS  Google Scholar 

  51. Lo SK, Fleming KA, Chapman RW. A two year follow-up study of antineutrophil antibody in primary sclerosing cholangitis. J Hepatol 1994; 21: 974–8.

    PubMed  CAS  Google Scholar 

  52. Terjung B, Spengler U, Sauerbruch T, Worman HJ. Atypical p-ANCA’ in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119: 310–22.

    PubMed  CAS  Google Scholar 

  53. Vierling JM. Immunologic and non-immunologic factors in the etiopathogenesis of sclerosing cholangitis. 2000 Clinical Research Single Topic Conference. Primary Sclerosing Cholangitis: Contovcrsics and Consensus. AASLD.

    Google Scholar 

  54. Wells IP, Wheeler PG, Laws JW, Williams R. A new appearance of the comon bile duct in sclerosing cholangitis. Br J Radiol 1980; 53: 502–4.

    Article  PubMed  CAS  Google Scholar 

  55. Fulcher AS, Turner MA, Franklin KJ et al. Primary sclerosing cholangitis: evaluation with MR cholangiography a case control study. Radiology 2000; 215: 71–80.

    PubMed  CAS  Google Scholar 

  56. Broomc U, Olsson R, Loof L et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610–15.

    Google Scholar 

  57. Wiesner RH, Grambsch PM, Dickson ER et al. Primary sclerosing cholangitis; natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–6

    PubMed  CAS  Google Scholar 

  58. Farrant JM, Hayllar KM, Wilkinson ML et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–17.

    PubMed  CAS  Google Scholar 

  59. Dickson ER, Murtaugh PA, Wiesner RH et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893–901.

    PubMed  CAS  Google Scholar 

  60. Kim WR, Poterucha JJ, Wiesner RH et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999; 29: 1643–8.

    PubMed  CAS  Google Scholar 

  61. May GR, Bender CE, LaRusson NF, Wiesner RH. Non operative dilatation of dominant strictures in primary sclerosing cholangitis. Am J Radiol 1985; 145: 1061–4.

    CAS  Google Scholar 

  62. Allison MC, Burroughs AK, Noone P, Summerfield JA. Biliary lavage with corticosteroids in primary sclerosing cholangitis. J Hepatol 1986; 3: 118–22.

    PubMed  CAS  Google Scholar 

  63. Lindor KD, Wiesner RH, Colwell LJ, Steiner BL, Beaver S, LaRusso NF. The combination of prednisolone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991; 85: 57–61.

    Google Scholar 

  64. Lindor KD. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 691–5.

    PubMed  CAS  Google Scholar 

  65. Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001; 121: 900–7.

    PubMed  CAS  Google Scholar 

  66. Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25: 1049–53.

    PubMed  CAS  Google Scholar 

  67. Goss JA, Shackleton CR, Farmer DG et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single centre experience. Ann Surg 1997; 225: 472–81.

    PubMed  CAS  Google Scholar 

  68. Graziadei IW, Wiesner RH, Batts KP et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29: 1050–6.

    PubMed  CAS  Google Scholar 

  69. Ahrendt SA, Pitt HA. Surgical treatment for primary sclerosing cholangitis. J Hepatobil Pane Surg 1999; 6: 366–72.

    CAS  Google Scholar 

  70. Mistilis SP. Pericholangitis and ulcerative colitis: (pathology, aetiology and pathogenesis). Ann Intern Med 1965; 63: 1–16.

    PubMed  CAS  Google Scholar 

  71. Mistilis SP, Skyring AP, Goulston SJM. Pericholangitis & ulcerative colitis: II. Clinical aspects. Ann Intern Med 1965; 63: 17–26.

    PubMed  CAS  Google Scholar 

  72. Boden RE, Rankin JG, Goulston SJ, Morrow W.v The liver in ulcerative colitis: the significance of raised serum alkaline phsophatase levels. Lancet 1959; 2: 245–8.

    PubMed  CAS  Google Scholar 

  73. Blackstone MO, Nemchausky BA. Cholangiographic abnormalities in ulcerative colitis associated pericholangitis which resemble sclerosing cholangitis. Dig Dis Sci 1978: 23: 579–85.

    CAS  Google Scholar 

  74. Shepherd HA, Selby WS, Chapman RW et al. Ulcerative colitis and liver dysfunction. Q Med 1983; 52: 503–13.

    CAS  Google Scholar 

  75. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small ducts? Ann Intern Med 1985; 102: 581–7.

    PubMed  CAS  Google Scholar 

  76. Broome U, Glaumann H, Lindstom E et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002; 36: 586–9.

    PubMed  Google Scholar 

  77. Bjornsson E, Cullen S, Fleming K et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002 (in press).

    Google Scholar 

  78. Desmet VJ, Geboes K. Liver lesions in inflammatory bowel disorders. J Pathol 1987; 151: 247–55.

    PubMed  CAS  Google Scholar 

  79. Olsson R, Hulten L. Concurrence of ulcerative colitis and chronic active hepatitis. Clinical courses and results of colectomy. Scand J Gastroenterol 1975; 10: 331–5.

    PubMed  CAS  Google Scholar 

  80. Hashimoto E, Lindor KD, Homburger HA et al. Immuno-histochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune hepatitis. Mayo Clin Proc 1993; 68: 1049–55.

    PubMed  CAS  Google Scholar 

  81. Gotike F, Lohse AW, Dienes HP et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24: 699–705.

    Google Scholar 

  82. Tumen HJ, Moaghan JF, Jobb E. Hepatic cirrhosis as a complication of chronic ulcerative colitis. Ann Intern Med 1947; 26: 542–53.

    PubMed  CAS  Google Scholar 

  83. Holdsworth CD, Hall EW, Dawson AM. Ulcerative colitis in chronic liver disease. Q Med 1965; 34: 211–26

    CAS  Google Scholar 

  84. Lupinetti M, Mehigan D, Cameron JL. Hepatobiliary complications of ulcerative colitis. Am Surg 1980; 139: 113–17.

    CAS  Google Scholar 

  85. Schrumpf E, Elgjo K, Fausa O, Gjone F, Kolmannskog F, Ritland S. Sclerosing cholangitis in ulcerative colitis. Scand Gastroenterol 1980; 15: 689–97.

    CAS  Google Scholar 

  86. Broome U, Glaumann H, Hellers G, Nilsson B, Sorstadt J, Hultcrantz R. Liver disease in ulcerative colitis: an epidimiologcal and follow-up study in the county of Stockholm. Gut 1994; 35: 84–9.

    PubMed  CAS  Google Scholar 

  87. Mir-Madjlessi SH, Farmer RG, Sivak MV. Bile duct carcinoma in patients with ulcerative colitis. Dig Dis Sci 1987; 32: 145–54.

    PubMed  CAS  Google Scholar 

  88. Berman MD, Falchuk KR, Trey C. Carcinoma of the biliary tree complicating Crohn’s disease. Dig Dis Sci 1980; 25: 795–7.

    PubMed  CAS  Google Scholar 

  89. Choi PM, Nugent FW, Zelig MP, Munson JL, Schoetz DJ Jr. Cholangiocarcinoma and Crohn’s disease. Dig Dis Sci 1994; 39: 667–70.

    PubMed  CAS  Google Scholar 

  90. Keiding S, Hansen SB, Rasmussen HH et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28: 700–6.

    PubMed  CAS  Google Scholar 

  91. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21–5.

    PubMed  CAS  Google Scholar 

  92. Stieber AL, Marino IR, Iwatsuki S, Starzl TE. Cholangiocarcinoma in sclerosing cholangitis: the role of liver transplantation. Int Surg 1989; 74: 1–3.

    PubMed  CAS  Google Scholar 

  93. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumour markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865–9.

    PubMed  CAS  Google Scholar 

  94. Harrison PM. Prevention of bile duct cancer in primary sclerosing cholangitis. Ann Oncol 1999; 10: 208–11.

    PubMed  Google Scholar 

  95. Finklestein S. Cholangiocarcinoma associated with primary sclerosing cholangitis. 2000 Clinical Research Single Topic Conference. Primary Sclerosing Cholangitis: Controversies and Consensus. AASLD.

    Google Scholar 

  96. Klompmaker IJ, DeBruign KM, Gouw AS, Bams JL, Sloof MJH. Recurrence of hepatocellular carcinoma after liver transplantation. Br Med J 1988; 296: 1445.

    CAS  Google Scholar 

  97. Snook JA, Kelly P, Chapman RW, Jewell DP. Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis. Gut 1989; 30: 243–5.

    PubMed  CAS  Google Scholar 

  98. Harnois DM, Goves GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for development of hepatocellular cancer? J Hepatol 1997; 27: 512–16.

    PubMed  CAS  Google Scholar 

  99. Eade MN. Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy. Ann Intern Med 1970; 72: 457–87.

    Google Scholar 

  100. Eade MN, Cooke WT, Brooke BN, Thompson H. Liver disease in Crohn’s colitis. A study of 21 consecutive patients having colectomy. Ann Intern Med 1970; 74: 518–28.

    Google Scholar 

  101. Cohen S, Kaplan M, Glottlieb L, Patterson L. Liver disease and gallstones in regional enteritis. Gastroenterology 1971; 60: 243–5.

    Google Scholar 

  102. Marks JW. Gallstone prevalence of biliary lipid composition in inflammatory bowel disease. Am Dig Dis 1977; 22: 1097–100.

    CAS  Google Scholar 

  103. Baker EJ, Merritt CRB, Sullivan MA et al Gallstones in inflammatory bowel disease. Am Dig Dis 1974; 19: 109–12.

    CAS  Google Scholar 

  104. Kangas E, Lehmusto P, Matikainen M. Gallstones in Crohn’s disease. Hepatogastroenterology 1990; 37: 83–4.

    PubMed  CAS  Google Scholar 

  105. Galatola G, Fracchia M, Gazrawi RP. Effect of colectomy with ileal and anal anastamosis on the biliary lipids. Eur J Clin Invest 1995; 25: 534–8.

    Article  PubMed  CAS  Google Scholar 

  106. Murray FE, McNicholas M, Stack W, O’Donoghue DP. Impaired fatty meal stimulated gall bladder contractivity in patients with Crohn’s disease. Clin Sci 1993; 83: 689–93.

    Google Scholar 

  107. Fausa O, Nygaard K, Elgjo K. Amyloidosis and Crohn’s disease. Scand J Gastroenterol 1977; 12: 657–62.

    Article  PubMed  CAS  Google Scholar 

  108. Mayer HL, Hughes RW, Jarrett HF, Mosenthal A. Granulomatous hepatitis associated with regional enteritis. Gastroenterology 1967; 53: 301–5.

    Google Scholar 

  109. Ludwig J, Colina F, Poterucha JJ. Granulomas in primary sclerosing cholangitis. Liver 1995; 15: 307–12.

    PubMed  CAS  Google Scholar 

  110. Greenstein AJ, Schar DB, Lowenthal D, Goldofsky E, Aufses AH. Pyogenic liver abscess in Crohn’s disease. Q J Med 1955; 56: 505–18.

    Google Scholar 

  111. Mir-Madjlessi SH, McHenry MC, Farmer RG. Liver abscess in Crohn’s disease. Gastroenterology 1986; 91: 987–93.

    PubMed  CAS  Google Scholar 

  112. Koulentaki M, Koutroubakis IE, Petinaki E et al. Ulcerative colitis associated with primary biliary cirrhosis. Dig Dis Sci 1999; 44: 1953–6.

    PubMed  CAS  Google Scholar 

  113. Brinson RR, Curtis WD, Schuman BM, Mills LR. Recovery from hepatic vein thrombosis (Budd-Chiari styndrome) complicating ulcerative colitis. Dig Dis Sci 1988; 33: 1615–20.

    PubMed  CAS  Google Scholar 

  114. Chesner IM, Muller S, Newman J. Ulcerative colitis complicated by Budd-Chiari syndrome. Gut 1986; 27: 1096–100.

    PubMed  CAS  Google Scholar 

  115. Kraut K, Berman JH, Gunasekaran TS et al. Hepatic vein thrombosis (Budd-Chiari syndrome) in an adolescent with ulcerative colitis. J Pediatr Gastroenterol Nutr 1997; 25: 417–20.

    PubMed  CAS  Google Scholar 

  116. Praderio L, Dagna L, Longhi P, Rubin G, Sabbadini MG. Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J Clin Gastroenterol 2000;30: 203–4.

    PubMed  CAS  Google Scholar 

  117. Maccini DM, Berg JC, Bell GA. Budd-Chiari and Crohn’s disease. An unreported association. Dig Dis Sci 1989; 34: 1615–20.

    Google Scholar 

  118. Braun M, Fraser GM, Kunin M, Salamon F, Kaspa RT. Mesalamine-induced granulomatous hepatitis. Am J Gastroenterol 1999;94: 1973–4.

    PubMed  CAS  Google Scholar 

  119. Delentre P, Berson A, Marcellin P, Degott C, Biour M, Pessayre D. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis. Gut 1999; 44: 886–8.

    Article  Google Scholar 

  120. Besnard M, Debray D, Durand P, Cezard JP, Navarro J. Sulfasalazine-induced fulminant hepatitis in pediatric Crohn’s disease: report of two cases. J Pediatr Gastroenterol Nutr 1998; 26: 119–20.

    PubMed  CAS  Google Scholar 

  121. Romagnuolo J, Sadowski DC, Lalor E, Jewell L, Thomson AB. Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Can J Gastroenterol 1998; 12: 479–83.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. John Radcliffe Hospital, Oxford, UK

    Sue Cullen & Roger Chapman

Authors
  1. Sue Cullen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Cullen, S., Chapman, R. (2003). Hepatobiliary disorders. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_38

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_38

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation